肿瘤坏死因子-α在心肌缺血再灌注损伤中的作用

张步升, 张郁林

张步升, 张郁林. 肿瘤坏死因子-α在心肌缺血再灌注损伤中的作用[J]. 实用临床医药杂志, 2009, (7): 115-117. DOI: 10.3969/j.issn.1672-2353.2009.07.048
引用本文: 张步升, 张郁林. 肿瘤坏死因子-α在心肌缺血再灌注损伤中的作用[J]. 实用临床医药杂志, 2009, (7): 115-117. DOI: 10.3969/j.issn.1672-2353.2009.07.048

肿瘤坏死因子-α在心肌缺血再灌注损伤中的作用

详细信息
  • 中图分类号: R542.2

  • 摘要: 心肌缺血再灌注损伤的发生、发展是个多因素协同作用的过程.文献报道其发生可能与氧自由基、中性粒细胞、细胞凋亡等因素有关[1-3].近年来,肿瘤坏死因子-α(TNF-α)在心肌缺血再灌注损伤过程中特别是在细胞凋亡中的作用越来越引起人们的关注,现就TNF-α在心肌缺血再灌注损伤中的作用机制综述如下:
  • 武俊芳, 许重洁, 范文艳. 急性缺血再灌注家兔心肌组织中半胱氨酸蛋白酶-3的表达和细胞凋亡及对心室功能的影响 [J]. 新乡医学院学报, 2008(4):325.doi: 10.3969/j.issn.1004-7239.2008.04.001.
    高翔, 高全, 李涛. 葛根素预处理保护心肌缺血再灌注损伤的机制 [J]. 贵阳医学院学报, 2007(1):37.doi: 10.3969/j.issn.1000-2707.2007.01.011.
    李娟, 朱爱娅, 杨国雄. 预处理延迟相对金属硫蛋白及缺血再灌注损伤心肌细胞凋亡的影响 [J]. 贵阳医学院学报, 2008(1):41.doi: 10.3969/j.issn.1000-2707.2008.01.013.
    Carswell E A, Old L J, Kassel R L. An endotoxin-induced serum factor that causes necrosis of tumors [J]. Proceedings of the National Academy of Sciences(USA), 1975(9):3666.
    Morgan M J, Kim Y S, Liu Z G. TNF-alpha and reactive oxygen species in necrotic cell death [J]. Cell Research, 2008(3):343.doi: 10.1038/cr.2008.31.
    Bartee E, Mohamed M R, McFadden G. Tumor necrosis factor and interferon:cytokinea in harmony [J]. Current Opinion in Microbiology, 2008(4):378.doi: 10.1016/j.mib.2008.05.015.
    Hundsberger H, Verin A, Wiesner C. TNF:a moonlighting protein at the interface between cancer and infection [J]. Frontiers in Bioscience, 2008.5374.doi: 10.2741/3087.
    Wang M, Tsai B M, Turrentine M W. P38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart [J]. Annals of Thoracic Surgery, 2005(6):2235.
    何国军, 黄明, 赖福生. 急性脑梗死并发全身炎症反应综合征患者血清肿瘤坏死因子-a和白细胞介素-10的变化及临床意义 [J]. 新乡医学院学报, 2008(4):371.doi: 10.3969/j.issn.1004-7239.2008.04.015.
    Zhang C, Xu X, Portter B J. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury [J]. Arteriosder Thromb Vase Biol, 2006(3):475.doi: 10.1161/01.ATV.0000201932.32678.7e.
    Kin H, Wang N P, Halkos M E. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion [J]. Journal of Surgical Research, 2006(1):170.doi: 10.1016/j.jss.2006.02.019.
    Kato T, Kitngawa S. Regulation of neutrophil functions by proinflammatory eytokines [J]. International Journal of Hematology, 2006(3):205.doi: 10.1532/IJH97.06141.
    Dhingra S, Sharma AK, Singla DK. P38andERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis [J].
    Haudek S B, Taffet G E, Schneider M D. TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways [J]. Journal of Clinical Investigation, 2007(9):2692.doi: 10.1172/JCI29134.
    Kieazko R, Krswczyk P, Chocholska S. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis [J]. Reapir Med, 2007(3):645.
    Mizoguchi E, Hachiya Y, Kawada M. TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality [J]. Geatroenterology, 2008(2):470.
    Peiretti F, Canault M, Bernot D. Proteasorne inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial calls [J]. J Call Sci, 2005(5):1061.
    Flaherty M P, Guo Y, TiwariS. The role of TNF-alpha receptors p55 and p75 in acute myocaxdial ischemia/reperfusion injury and late preconditioning [J]. Journal of Molecular and Cellular Cardiology, 2008(6):735.doi: 10.1016/j.yjmcc.2008.08.014.
    Eclde T, Kohler D, Lehmann R. Hypoxia-inducible factor-1 is central to cardioprotection:a new paradigm for ischemic precenditioning [J]. Circulation, 2008(2):166.doi: 10.1161/CIRCULATIONAHA.107.758516.
    Moulin M, Carpentier S, Levade T. Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis [J]. Apoptosis:An International Journal on Programmed Cell Death, 2007(9):1703.
    Scelinger G, Merfort I, Schempp CM. Anti-oxidant, antiinflammatory and anti-allergic activities of luteolin [J]. Planta Medica, 2008, (14):1667.doi: 10.1055/s-0028-1088314.
    Kimura H, Shintani-lshida K, Nakajima M. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia [J]. Life Sciences, 2006, (17):1901.doi: 10.1016/j.lfs.2005.08.040.
    Gross E R, Gross G J. Ischemic Preconditioning And Myocardial Infarction:An Update and Perspective [J]. Drug Today Dis Mech, 2007(3):165.doi: 10.1016/j.ddmec.2007.10.005.
    Sun H Y, Wang N P, Halkos M. Postconditioning attenuatea cardiornyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways [J]. Apoptosis:An International Journal on Programmed Cell Death, 2006(9):1583.
    Sadat U, Walsh S R, Varty K. Cardioproteetion by ischeraic postconditioning during surgical procedurea [J]. Expert Review of Cardiovascular Therapy, 2008(7):999.doi: 10.1586/14779072.6.7.999.
计量
  • 文章访问数:  268
  • HTML全文浏览量:  20
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 发布日期:  2009-06-11

目录

    /

    返回文章
    返回
    x 关闭 永久关闭